Country: United Kingdom Exchange: IOB Sector: Healthcare Industry: Biotechnology Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
United Kingdom (24)
- {{country.name}}
- All countries
- United Kingdom (24)
IOB (24)
- {{item.name}}
- All exchanges
- Aquis AQSE (1)
- IOB (24)
Healthcare (24)
- {{item.name}}
- All sectors
- Healthcare (24)
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | Prediction |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | Prediction | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
Novo Nordisk A/S
0QIU.IL
GB
|
DKK 305.15 44.74 USD |
+2.65
|
DKK 1.28T 187.87B USD | DKK 768.72K 112.71K USD | DKK 297.05 43.55 USD | DKK 309.85 45.43 USD | DKK 1.28T 187.87B USD | 20.53 | DKK 14.86 2.18 USD | ||
|
UCB SA
0NZT.IL
GB
|
€251.95 290.83 USD |
+1.9
|
€51.26B 59.18B USD | €114.84K 132.56K USD | €245.70 283.62 USD | €253.80 292.97 USD | €51.26B 59.18B USD | 148.20 | €1.70 1.96 USD | ||
argenx SE
0QW0.IL
GB
|
€812.00 937.32 USD |
+2.32
|
€47.77B 55.14B USD | €105.57K 121.86K USD | €793.00 915.39 USD | €813.40 938.94 USD | €47.77B 55.14B USD | 0 | -€6.55 -7.5 USD | ||
|
Moderna, Inc.
0A45.IL
GB
|
$62.05 — |
+6.71
|
$30.17B — | $40.77K — | $56.00 — | $63.97 — | $30.17B — | 23.15 | $2.68 — | ||
ALK-Abelló A/S
0OIR.IL
GB
|
DKK 149.45 21.91 USD |
0
|
DKK 30.00B 4.4B USD | DKK 30.67K 4.5K USD | DKK 254.29 37.28 USD | DKK 256.60 37.62 USD | DKK 30.00B 4.4B USD | 92.82 | DKK 1.61 0.24 USD | ||
|
Zealand Pharma A/S
0NZU.IL
GB
|
DKK 289.30 42.42 USD |
+1.47
|
DKK 17.25B 2.53B USD | DKK 63.10K 9.25K USD | DKK 285.00 41.79 USD | DKK 296.80 43.52 USD | DKK 17.25B 2.53B USD | 0 | -DKK 15.13 -2.2 USD | ||
Idorsia Ltd
0RQE.IL
GB
|
CHF 5.94 7.44 USD |
+4.26
|
CHF 1.51B 1.89B USD | CHF 251.63K 315.6K USD | CHF 5.69 7.13 USD | CHF 6.02 7.54 USD | CHF 1.51B 1.89B USD | 0 | -CHF 4.57 -5.7 USD | ||
Pharma Mar, S.A.
0RC6.IL
GB
|
€68.90 79.53 USD |
+0.66
|
€1.25B 1.44B USD | €681.00 786.1 USD | €67.90 78.38 USD | €69.55 80.28 USD | €1.25B 1.44B USD | 62.07 | €1.11 1.28 USD | ||
|
Pharming Group N.V.
0QCO.IL
GB
|
€1.17 1.35 USD |
+2.84
|
€914.76M 1.06B USD | €1.23M 1.42M USD | €1.14 1.31 USD | €1.17 1.35 USD | €914.76M 1.06B USD | 0 | -€0.02 -0.02 USD | ||
|
DBV Technologies S.A.
0QAJ.IL
GB
|
€2.85 3.29 USD |
+2.44
|
€323.38M 373.29M USD | €12.89K 14.88K USD | €2.77 3.2 USD | €2.84 3.28 USD | €323.38M 373.29M USD | 0 | -€0.93 -1.07 USD | ||
|
Cellectis S.A.
0WA2.IL
GB
|
€2.53 2.92 USD |
+2.51
|
€182.75M 210.95M USD | €535.00 617.57 USD | €2.41 2.78 USD | €2.47 2.85 USD | €182.75M 210.95M USD | 0 | -€1.42 -1.6 USD | ||
|
Innate Pharma S.A.
0EVI.IL
GB
|
€1.66 1.91 USD |
+3.18
|
€133.44M 154.03M USD | €9.03K 10.42K USD | €1.59 1.83 USD | €1.64 1.9 USD | €133.44M 154.03M USD | 0 | -€0.78 -0.9 USD | ||
|
Oncopeptides AB (publ)
0RN4.IL
GB
|
SEK 1.66 0.16 USD |
-1.34
|
SEK 169.99M 16.59M USD | SEK 0.00 0 USD | SEK 1.70 0.17 USD | SEK 1.70 0.17 USD | SEK 169.99M 16.59M USD | 0 | -SEK 3.39 -0.3 USD | ||
Poxel S.A.
0RA2.IL
GB
|
€0.20 0.23 USD |
-3.33
|
€7.07M 8.16M USD | €258.00 297.82 USD | €0.20 0.23 USD | €0.20 0.23 USD | €7.07M 8.16M USD | 0 | -€1.09 -1.2 USD | ||
|
BioNTech SE
0A3M.IL
GB
|
$90.75 — |
0
|
$24.96B — | $859.00 — | $89.60 — | $91.73 — | $24.96B — | 5.04 | $18.00 — | ||
|
Genmab A/S
0MGB.IL
GB
|
DKK 1,706.50 250.21 USD |
+3.57
|
DKK 136.66B 20.04B USD | DKK 4.21K 616.98 USD | DKK 1,666.00 244.27 USD | DKK 1,709.00 250.58 USD | DKK 136.66B 20.04B USD | 24.11 | DKK 70.77 10.38 USD | ||
|
BioArctic AB (publ)
0RV2.IL
GB
|
SEK 310.70 30.33 USD |
-1.52
|
SEK 31.08B 3.03B USD | SEK 858.00 83.75 USD | SEK 309.90 30.25 USD | SEK 315.00 30.75 USD | SEK 31.08B 3.03B USD | 101.20 | SEK 3.07 0.3 USD | ||
|
Bavarian Nordic A/S
0DPB.IL
GB
|
DKK 176.00 25.81 USD |
+2.59
|
DKK 16.52B 2.42B USD | DKK 17.98K 2.64K USD | DKK 171.60 25.16 USD | DKK 177.10 25.97 USD | DKK 16.52B 2.42B USD | 12.49 | DKK 14.09 2.07 USD | ||
|
Lakefront Biotherapeutics NV
0JXZ.IL
GB
|
€25.21 29.1 USD |
+0.84
|
€1.66B 1.92B USD | €1.25K 1.44K USD | €25.18 29.07 USD | €25.52 29.46 USD | €1.66B 1.92B USD | 0 | -€2.44 -2.8 USD | ||
CureVac N.V.
0A9E.IL
GB
|
$5.13 — |
0
|
$1.28B — | $0.00 — | $0.00 — | $0.00 — | $1.28B — | 0 | $0.00 — | ||
Genfit S.A.
0QT6.IL
GB
|
€10.99 12.69 USD |
+3.1
|
€586.44M 676.95M USD | €8.27K 9.54K USD | €10.36 11.96 USD | €11.06 12.77 USD | €586.44M 676.95M USD | 0 | -€0.67 -0.7 USD | ||
|
BioInvent International AB (publ)
0H22.IL
GB
|
SEK 23.73 2.32 USD |
+2.04
|
SEK 1.67B 162.94M USD | SEK 0.00 0 USD | SEK 23.10 2.25 USD | SEK 23.10 2.25 USD | SEK 1.67B 162.94M USD | 0 | -SEK 5.01 -0.4 USD | ||
|
Thor Medical ASA
0R6Y.IL
GB
|
NOK 4.18 0.4 USD |
-0.42
|
NOK 1.20B 115.02M USD | NOK 12.17K 1.17K USD | NOK 4.13 0.4 USD | NOK 4.21 0.4 USD | NOK 1.20B 115.02M USD | 0 | -NOK 1.17 -0.1 USD | ||
|
Hansa Biopharma AB (publ)
0RC7.IL
GB
|
SEK 34.31 3.35 USD |
+1.87
|
SEK 48.77M 4.76M USD | SEK 6.16K 600.8 USD | SEK 34.14 3.33 USD | SEK 35.16 3.43 USD | SEK 48.77M 4.76M USD | 0 | -SEK 16.03 -1.5 USD | ||
|
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
|||||||||||
- {{ link.label }} {{link}}